These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
313 related items for PubMed ID: 23308230
1. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors. Kwak MK, Johnson DT, Zhu C, Lee SH, Ye DW, Luong R, Sun Z. PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230 [Abstract] [Full Text] [Related]
2. Conditional expression of the androgen receptor induces oncogenic transformation of the mouse prostate. Zhu C, Luong R, Zhuo M, Johnson DT, McKenney JK, Cunha GR, Sun Z. J Biol Chem; 2011 Sep 23; 286(38):33478-88. PubMed ID: 21795710 [Abstract] [Full Text] [Related]
3. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision. Luchman HA, Benediktsson H, Villemaire ML, Peterson AC, Jirik FR. PLoS One; 2008 Sep 23; 3(12):e3940. PubMed ID: 19081794 [Abstract] [Full Text] [Related]
4. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis. Ma X, Ziel-van der Made AC, Autar B, van der Korput HA, Vermeij M, van Duijn P, Cleutjens KB, de Krijger R, Krimpenfort P, Berns A, van der Kwast TH, Trapman J. Cancer Res; 2005 Jul 01; 65(13):5730-9. PubMed ID: 15994948 [Abstract] [Full Text] [Related]
5. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate. Mi J, Hooker E, Balog S, Zeng H, Johnson DT, He Y, Yu EJ, Wu H, Le V, Lee DH, Aldahl J, Gonzalgo ML, Sun Z. J Biol Chem; 2018 Dec 28; 293(52):20123-20136. PubMed ID: 30401749 [Abstract] [Full Text] [Related]
6. Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma. Adisetiyo H, Liang M, Liao CP, Aycock-Williams A, Cohen MB, Xu S, Neamati N, Conway EM, Cheng CY, Nikitin AY, Roy-Burman P. PLoS One; 2013 Dec 28; 8(7):e69484. PubMed ID: 23936028 [Abstract] [Full Text] [Related]
7. Deletion of the p16INK4a tumor suppressor and expression of the androgen receptor induce sarcomatoid carcinomas with signet ring cells in the mouse prostate. Lee DH, Yu EJ, Aldahl J, Yang J, He Y, Hooker E, Le V, Mi J, Olson A, Wu H, Geradts J, Xiao GQ, Gonzalgo ML, Cardiff RD, Sun Z. PLoS One; 2019 Dec 28; 14(1):e0211153. PubMed ID: 30677079 [Abstract] [Full Text] [Related]
8. Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma. Ratnacaram CK, Teletin M, Jiang M, Meng X, Chambon P, Metzger D. Proc Natl Acad Sci U S A; 2008 Feb 19; 105(7):2521-6. PubMed ID: 18268330 [Abstract] [Full Text] [Related]
9. The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression. Olson A, Le V, Aldahl J, Yu EJ, Hooker E, He Y, Lee DH, Kim WK, Cardiff RD, Geradts J, Sun Z. PLoS Genet; 2019 Oct 19; 15(10):e1008451. PubMed ID: 31658259 [Abstract] [Full Text] [Related]
10. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways. Xing C, Ci X, Sun X, Fu X, Zhang Z, Dong EN, Hao ZZ, Dong JT. Neoplasia; 2014 Nov 19; 16(11):883-99. PubMed ID: 25425963 [Abstract] [Full Text] [Related]
11. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias. Mirantes C, Eritja N, Dosil MA, Santacana M, Pallares J, Gatius S, Bergadà L, Maiques O, Matias-Guiu X, Dolcet X. Dis Model Mech; 2013 May 19; 6(3):710-20. PubMed ID: 23471917 [Abstract] [Full Text] [Related]
12. Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice. Blando JM, Carbajal S, Abel E, Beltran L, Conti C, Fischer S, DiGiovanni J. Neoplasia; 2011 Mar 19; 13(3):254-65. PubMed ID: 21390188 [Abstract] [Full Text] [Related]
13. PTEN loss and activation of K-RAS and β-catenin cooperate to accelerate prostate tumourigenesis. Jefferies MT, Cox AC, Shorning BY, Meniel V, Griffiths D, Kynaston HG, Smalley MJ, Clarke AR. J Pathol; 2017 Dec 19; 243(4):442-456. PubMed ID: 29134654 [Abstract] [Full Text] [Related]
14. Accumulating progenitor cells in the luminal epithelial cell layer are candidate tumor initiating cells in a Pten knockout mouse prostate cancer model. Korsten H, Ziel-van der Made A, Ma X, van der Kwast T, Trapman J. PLoS One; 2009 May 22; 4(5):e5662. PubMed ID: 19461893 [Abstract] [Full Text] [Related]
15. Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression. Vinall RL, Chen JQ, Hubbard NE, Sulaimon SS, Shen MM, Devere White RW, Borowsky AD. Dis Model Mech; 2012 Nov 22; 5(6):914-20. PubMed ID: 22563073 [Abstract] [Full Text] [Related]
16. Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression. Higgins J, Brogley M, Palanisamy N, Mehra R, Ittmann MM, Li JZ, Tomlins SA, Robins DM. Horm Cancer; 2015 Jun 22; 6(2-3):67-86. PubMed ID: 25631336 [Abstract] [Full Text] [Related]
17. Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Huang J, Powell WC, Khodavirdi AC, Wu J, Makita T, Cardiff RD, Cohen MB, Sucov HM, Roy-Burman P. Cancer Res; 2002 Aug 15; 62(16):4812-9. PubMed ID: 12183441 [Abstract] [Full Text] [Related]
18. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Zhong C, Saribekyan G, Liao CP, Cohen MB, Roy-Burman P. Cancer Res; 2006 Feb 15; 66(4):2188-94. PubMed ID: 16489020 [Abstract] [Full Text] [Related]
19. Additive Effect of Zfhx3/Atbf1 and Pten Deletion on Mouse Prostatic Tumorigenesis. Sun X, Xing C, Fu X, Li J, Zhang B, Frierson HF, Dong JT. J Genet Genomics; 2015 Jul 20; 42(7):373-82. PubMed ID: 26233892 [Abstract] [Full Text] [Related]
20. Conditional transgenic expression of PIM1 kinase in prostate induces inflammation-dependent neoplasia. Narlik-Grassow M, Blanco-Aparicio C, Cecilia Y, Perez M, Muñoz-Galvan S, Cañamero M, Renner O, Carnero A. PLoS One; 2013 Jul 20; 8(4):e60277. PubMed ID: 23565217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]